Bioton SA

WAR:BIO (Poland)  
zł 2.80 (-0.36%) Dec 27
On watch
At Loss
P/B:
0.41
Market Cap:
zł 241.28M ($ 58.88M)
Enterprise V:
zł 292.70M ($ 71.42M)
Volume:
110.05K
Avg Vol (2M):
44.51K
Warning! GuruFocus detected 3 Severe warning signs with BIO. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
110.05K
Market Cap zł:
241.28M
Market Cap $:
58.88M
At Loss
Avg Vol (2M):
44.51K
Enterprise Value zł:
292.70M
Enterprise Value $:
71.42M
PB Ratio:
0.41
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Bioton SA

ISIN : PLBIOTN00029
http://www.bioton.pl
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Compare
Compare
WAR:SVEWAR:CTXWAR:PTGWAR:MOCWAR:MABWAR:BCXWAR:URTWAR:NNGWAR:PURWAR:RDGVRTXASX:CSLREGNXKRX:207940XBRU:ARGXXBRU:UCBALNYXKRX:068270BNTXBGNE
Traded in other countries / regions
BIO.Poland7U5.Germany0DTR.UK
IPO Date
2005-03-31
Description
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Financials

WAR:BIO's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bioton SA Executives

Details

GF Value: zł3.23

WAR:BIO

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł) 177.597
EPS (TTM) (zł) -0.063
Beta 0.3
Volatility % 6.89
14-Day RSI 18.11
14-Day ATR (zł) 0.075225
20-Day SMA (zł) 3.07725
12-1 Month Momentum % -8.63
52-Week Range (zł) 2.795 - 3.775
Shares Outstanding (Mil) 85.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bioton SA Filings

Filing Date Document Date Form
No Filing Data

Bioton SA Stock Events

Financials Calendars
Event Date Price(zł)
No Event Data

Bioton SA Frequently Asked Questions

What is Bioton SA(WAR:BIO)'s stock price today?
The current price of WAR:BIO is zł2.80. The 52 week high of WAR:BIO is zł3.78 and 52 week low is zł2.80.
When is next earnings date of Bioton SA(WAR:BIO)?
The next earnings date of Bioton SA(WAR:BIO) is .
Does Bioton SA(WAR:BIO) pay dividends? If so, how much?
Bioton SA(WAR:BIO) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.